Sign up
Quantellect · Congress · Trade Detail
NYSE: NVSNovartis AG ADR
RepublicanHouse

James B. Renacci bought Novartis AG ADR (NYSE: NVS)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 16 trades in Novartis AG ADR (NVS) since 2015, 11 purchases and 5 sales, worth an estimated $525K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of Novartis AG ADR (NYSE: NVS) on July 17, 2015. Since that trade, NVS is up +150.90% against the S&P 500 up +310.72%, an outperformance of -159.82%.

Across these filings, James B. Renacci has been a net buyer of NVS (a buy-to-sell ratio of 2.20). The most recent disclosed NVS transaction shown was dated November 21, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

NVS trades
16
Disclosed Vol
$525K
Buys
11
69%
Sells
5
31%
Buy / Sell
2.20
ratio
First → Last
2015–2018

James B. Renacci's NVS trades vs the price

NVS is up +150.90% since James B. Renacci bought on July 17, 2015, versus +310.72% for the S&P 500.

Performance since this trade

Price change since trade
+150.90%
S&P 500 change since trade
+310.72%
Outperformance vs S&P 500
-159.82%

All James B. Renacci NVS trades

TradedTypeSizeReturnEst. profit
November 21, 2018BUY$59.45+167.15%+$6K
September 20, 2018BUY$57.41+176.66%+$64K
September 19, 2018BUY$56.70+180.14%+$28K
November 17, 2017BUY$54.10+193.58%+$7K
March 16, 2017SELL$48.75+225.82%
January 23, 2017SELL$43.60+264.31%
January 13, 2017BUY$45.00+252.94%+$39K
December 13, 2016SELL$44.27+258.78%
August 26, 2016BUY$49.30+222.19%+$8K
June 8, 2016SELL$50.59+213.95%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & NVS trading FAQ

Is it legal for James B. Renacci to trade Novartis AG ADR (NVS) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci buy NVS?

James B. Renacci disclosed a purchase of $1,000 - $15,000 of Novartis AG ADR (NVS) on July 17, 2015, according to public STOCK Act filings.

How has NVS performed since James B. Renacci's trade?

Since James B. Renacci bought NVS on July 17, 2015, the stock is up +150.90%, versus +310.72% for the S&P 500 over the same period, an outperformance of -159.82%.

How many times has James B. Renacci traded NVS?

James B. Renacci has disclosed 16 NVS trades since 2015 (11 purchases and 5 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional NVS trades?

Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's NVS tradesAll congressional filings for Novartis AG ADRJames B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.